Canaccord Genuity Reiterates Buy Rating on Intellia Therapeutics (NTLA)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: NTLA) | Delayed: 12.23 +0.37 (3.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.86 | 52 Week High | $30.40 | |||
| Open | $12.26 | 52 Week Low | $11.86 | |||
| Day High | $12.53 | P/E | N/A | |||
| Day Low | $11.90 | EPS | $0.00 | |||
| Volume | 961,731 | |||||
